PM Thoresen Asia Holdings Valuation
Is PMTA-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PMTA-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PMTA-R (THB9.2) is trading above our estimate of fair value (THB5.18)
Significantly Below Fair Value: PMTA-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PMTA-R?
Other financial metrics that can be useful for relative valuation.
What is PMTA-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿931.04m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.3x |
Enterprise Value/EBITDA | 5.3x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does PMTA-R's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 19.7x | ||
PATO Pato Chemical Industry | 18.2x | n/a | ฿1.3b |
NFC NFC | 18.3x | n/a | ฿3.3b |
TCCC Thai Central Chemical | 22.3x | n/a | ฿16.4b |
SUTHA Golden Lime | 20.3x | n/a | ฿935.0m |
PMTA-R PM Thoresen Asia Holdings | 16x | n/a | ฿931.0m |
Price-To-Earnings vs Peers: PMTA-R is good value based on its Price-To-Earnings Ratio (16x) compared to the peer average (18.9x).
Price to Earnings Ratio vs Industry
How does PMTA-R's PE Ratio compare vs other companies in the TH Chemicals Industry?
Price-To-Earnings vs Industry: PMTA-R is good value based on its Price-To-Earnings Ratio (16x) compared to the TH Chemicals industry average (16.7x).
Price to Earnings Ratio vs Fair Ratio
What is PMTA-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 16x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PMTA-R's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.